Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 543 results for "serum institute of india"

NeuClone to collaborate with Serum Institute of India

NeuClone has retained licence to the jointly developed biosimilars for the developed markets of USA, Europe, Canada, Australia, Taiwan. MELBOURNE: Sydney based biotechnology company NeuClone has inked a licensing agreement and joint development partnership ... Economic Times, 2 weeks ago
Biotech start-up signs deal with Indian giant Individual.com, 1 day ago
Serum Institute teams up with Australian biotech firm Hindu Business Line, 2 weeks ago
[x]  

5 images for serum institute of india

ABC News 4 Charleston, 2 months ago
I Stock Analyst, 2 months ago
The Hindu, 4 months ago
Racing Pulse, 3 months ago
Sakaal Times, 4 months ago
Forbes.com

No bidding war for Grosvenor House, says Poonawala

Cyrus Poonawalla, chairman, Serum Institute of India, is set to increase his bid for the iconic Grosvenor House hotel property in London to close to $935 million after the present owner Sahara group has put it on the block to meet its liquidity ...
 Sify2 days ago Vaccine Billionaire Cyrus Poonawalla Joins Race For London's Grosvenor House Hotel  Forbes.com6 days ago
Rediff.com

I doubt if Sahara is serious about selling properties: Adar Poonawalla

Owners of Pune-based Serum Institute of India, the Poonawalla's have thrown the hat to acquire the iconic Grosvenor Hotel in UK from Sahara Group. Adar Poonawalla, CEO of Serum Institute and son of Cyrus Poonawalla is categorical that they are only ...
 Smart Investor1 day ago 'I doubt if Sahara is serious about selling properties'  Rediff.com1 day ago

Serum Institute doses first patient in Phase IIa anemia study

(MarketLine via COMTEX News Network) -- Xenetic Biosciences, Inc., a biopharmaceutical company, has announced that its partner, the Serum Institute of India, has dosed first patient in the second cohort of a Phase IIa clinical, sequential single ...
 PredictWallStreet1 month ago

Global Meningococcal Vaccines Market - Forecasts to 2019: Sanofi, Novartis, GlaxoSmithKline, Pfizer, Serum Institute of India, JN-International, Nuron, Baxter and Biomed

/PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rd8s6p/meningococcal ) has announced the addition of the " " report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Meningococcal disease ...
 OSIX News2 months ago
[x]  

Findings from Serum Institute of India in the Area of Vaccines Reported (Structure function attributes of gold nanoparticle vaccine association:...

Findings from Serum Institute of India in the Area of Vaccines Reported (Structure function attributes of gold nanoparticle vaccine association: Effect of particle size and association temperature) By a News Reporter-Staff News Editor at Vaccine ...
 HispanicBusiness.com12 hours ago
[x]  

Xenetic doses first patient on dialysis in Phase II trial of ErepoXen

US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) ...
 Pharmaceutical Business Review1 month ago

Breather for Orchid as CLB refuses to stay debt recast

In a breather to Orchid Chemicals & Pharmaceuticals, the Company Law Board has dismissed an application filed by Serum Institute of India, seeking an interim injunction on Orchid's debt recast and a business transfer deal with Hospira India. ...
 Hindu Business Line2 months ago ORCHID CHEMICALS & PHARMACEUTICALS : Breather for orchid as clb refuses to stay debt recast  4 Traders2 months ago
Business Standard India

No stay on Orchid Pharma loan rejig

The interim order was issued on an application filed by Serum Institute, Cyrus Poonawalla and his firms BS Reporter | Chennai May 22, 2014 Last Updated at 23:32 IST The southern regional bench of the Company Law Board (CLB) has dismissed a request ...
 Business Standard India2 months ago
Business Standard India

CLB dismisses Serum Institute's plea to stay Orchid Chemicals' CDR

The Southern Regional Bench of Company Law Board (CLB) has issued an order dismissing a request of billionaire Cyrus Poonawalla and his firms seeking an injunction restraining Orchid Chemicals and Pharmaceuticals Ltd from implementing its Corporate ...
 Business Standard India2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less